Wasatch Pharmaceutical Inc Sample Contracts

AutoNDA by SimpleDocs
RECITALS
Settlement Agreement and Release • April 24th, 2001 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks • Texas
WITNESSETH RECITALS
Business Consulting Agreement • April 26th, 2002 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks • Utah
WITNESSETH
Consulting Agreement • April 4th, 2002 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks • California
WITNESSETH RECITALS
Business Consulting Agreement • April 4th, 2002 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks • Utah
WASATCH PHARMACEUTICAL Bryan Kos Stock Option Plan OPTION TO PURCHASE UP TO 1,600,000 SHARES OF COMMON STOCK
Wasatch Pharmaceutical Inc • January 2nd, 2001 • Phonograph records & prerecorded audio tapes & disks • Utah
RECITALS:
Common Stock Purchase Agreement • July 9th, 2001 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks • Utah
OPTION TO PURCHASE UP TO 4,100,000 SHARES OF COMMON STOCK
Wasatch Pharmaceutical Inc • January 2nd, 2001 • Phonograph records & prerecorded audio tapes & disks • Utah
Name Shares Issued ------------------ ------------- Gary Heesch 58,158,589 David Giles 45,032,787 Robert Arbon 6,808,624 ----------- Total 110,000,000 ===========
Compensatory Stock Issue Agreement • February 28th, 2002 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks

This Compensatory Stock Issue Agreement (herein after referred to as The Agreement) has been entered into by Wasatch Pharmaceutical, Inc. (herein after referred to as "Wasatch"), Gary Heesch, Wasatch CEO, David Giles, Wasatch CFO, and Robert Arbon, Wasatch Director, (herein after collectively referred to as "Officers") and Standard Registrar & Transfer Co., Inc. (herein after referred to as "Share Administrator") for the purpose of providing the aforementioned Officers with assurance that they will be adequately compensated for their loyal past and future services.

RECITALS:
Common Stock Purchase Agreement • July 9th, 2001 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks • Utah
Robert Weiss, Investor Relations Gary V. Heesch, CEO National Financial Network Wasatch Pharmaceutical, Inc. (781) 444-6100 ext. 11 (801) 566-9688 FOR IMMEDIATE RELEASE: WASATCH PHARMACEUTICAL SIGNS MULTIMILLION DOLLAR FINANCING AGREEMENT -- Company...
Wasatch Pharmaceutical Inc • May 4th, 2000 • Phonograph records & prerecorded audio tapes & disks

Midvale, Utah - April 28, 2000: Wasatch Pharmaceutical, Inc. (OTC BB: WASP), a leader in the research, development and distribution of dermatological treatments for skin disorders including acne and psoriasis, today announced that it has signed a financing agreement with Aspen Financial Resources that will bring the Company more than $10 million over the next 36 months.

Name Shares Issued ----------------- ------------- Gary Heesch 58,158,589 David Giles 45,032,787 Robert Arbon 6,808,624 ----------- Total 110,000,000 ===========
Compensatory Stock Issue Agreement • April 26th, 2002 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks
AGREEMENT
Agreement • March 11th, 1998 • Wasatch Pharmaceutical Inc • Phonograph records & prerecorded audio tapes & disks
AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.